HB Wealth Management »

Fate Therapeutics shares owned by HB Wealth Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $31k 11k 2.70

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Series Trust ST STR P500GRW (SPYG)
Gmo Etf Trust Us Quality Etf (QLTY)
Home Depot (HD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for HB Wealth Management

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics